{"id":"W4281800226","doi":"10.51731/cjht.2022.343","title":"Enfortumab Vedotin (Padcev)","year":2022,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":2,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Medicine; Urothelial cancer; Drug; Anticancer drug; Internal medicine; Oncology; Cancer; Pharmacology; Political science","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01833883,0.000142595,0.000934674,0.001438724,0.0008946713,0.00005260715,0.0007920948,0.00009828016,0.0007199559],"category_scores_gemma":[0.003991229,0.0001841227,0.0001328226,0.0004194346,0.0001342439,0.0002690018,0.00006212198,0.000679992,0.0001759425],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.002781774,"about_ca_system_score_gemma":0.004061933,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.01616882,"about_ca_topic_score_gemma":0.002670398,"domain_scores_codex":[0.994478,0.0002621406,0.004250527,0.0002454843,0.0001098847,0.000653903],"domain_scores_gemma":[0.9949428,0.0002722836,0.004124544,0.0004239196,0.00007211581,0.0001643552],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00001799726,0.00008232972,0.07218299,0.000448066,0.0001511348,0.00008276706,0.004682051,0.001300648,0.000001213612,0.4361058,0.4336206,0.05132442],"study_design_scores_gemma":[0.0004071158,0.0003177543,0.006277686,0.00004083568,0.000001967243,0.0001651836,0.01170999,0.0001325833,0.000002741672,0.04629182,0.9344605,0.0001917893],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"commentary","genre_gemma":"empirical","genre_scores_codex":[0.1486968,0.1827793,0.002092639,0.6573904,0.004044584,0.0008653754,0.000728372,0.0002081053,0.003194513],"genre_scores_gemma":[0.9873663,0.0001991202,0.001295559,0.01077572,0.00004084954,0.00003775565,0.000008071515,0.00002578496,0.0002508053],"genre_candidate":"empirical","genre_consensus":null,"teacher_disagreement_score":0.8386695,"threshold_uncertainty_score":0.9903826,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.3542821329863515,"score_gpt":0.4064495632101858,"score_spread":0.05216743022383435,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}